Images of normal (above) and diseased retinas. Patients with MFRP mutations, a cause of retinitis pigmentosa, lose the function of most retinal cells, particularly at the periphery of the retina, leaving them with drastically reduced vision. Personalized gene therapy, using iPS cells, may offer a way to correct this genetic disorder. Click here for animated version.(Image credit: Lab of Stephen H. Tsang, MD, PhD/Columbia University Medical Center.)
NEW YORK, NY (July 10, 2014) Columbia University Medical Center (CUMC) researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss. The approach, the first of its kind, takes advantage of induced pluripotent stem (iPS) cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.
Using this approach, researchers led by Stephen H. Tsang, MD, PhD, showed that a form of RP caused by mutations to the gene MFRP (membrane frizzled-related protein) disrupts the protein that gives retinal cells their structural integrity. They also showed that the effects of these mutations can be reversed with gene therapy. The approach could potentially be used to create personalized therapies for other forms of RP, as well as other genetic diseases. The paper was published recently in the online edition of Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
The use of patient-specific cell lines for testing the efficacy of gene therapy to precisely correct a patients genetic deficiency provides yet another tool for advancing the field of personalized medicine, said Dr. Tsang, the Laszlo Z. Bito Associate Professor of Ophthalmology and associate professor of pathology and cell biology.
While RP can begin during infancy, the first symptoms typically emerge in early adulthood, starting with night blindness. As the disease progresses, affected individuals lose peripheral vision. In later stages, RP destroys photoreceptors in the macula, which is responsible for fine central vision. RP is estimated to affect at least 75,000 people in the United States and 1.5 million worldwide.
More than 60 different genes have been linked to RP, making it difficult to develop models to study the disease. Animal models, though useful, have significant limitations because of interspecies differences. Researchers also use human retinal cells from eye banks to study RP. As these cells reflect the end stage of the disease process, however, they reveal little about how the disease develops. There are no human tissue culture models of RP, as it would dangerous to harvest retinal cells from patients. Finally, human embryonic stem cells could be useful in RP research, but they are fraught with ethical, legal, and technical issues.
The use of iPS technology offers a way around these limitations and concerns. Researchers can induce the patients own skin cells to revert to a more basic, embryonic stem celllike state. Such cells are pluripotent, meaning that they can be transformed into specialized cells of various types.
In the current study, the CUMC team used iPS technology to transform skin cells taken from two RP patientseach with a different MFRP mutationinto retinal cells, creating patient-specific models for studying the disease and testing potential therapies.
By analyzing these cells, the researchers found that the primary effect of MFRP mutations is to disrupt the regulation of actin, the protein that makes up the cytoskeleton, the scaffolding that gives the cell its structural integrity. Normally, the cytoskeleton looks like a series of connected hexagons, said Dr. Tsang. If a cell loses this structure, it loses its ability to function.
The researchers also found that MFRP works in tandem with another gene, CTRP5, and that a balance between the two genes is required for normal actin regulation.
In the next phase of the study, the CUMC team used adeno-associated viruses (AAVs) to introduce normal copies of MFRP into the iPS-derived retinal cells, successfully restoring the cells function. The researchers also used gene therapy to rescue mice with RP due to MFRP mutations. According to Dr. Tsang, the mice showed long-term improvement in visual function and restoration of photoreceptor numbers.
This study provides both in vitro and in vivo evidence that vision loss caused by MFRP mutations could potentially be treated through AAV gene therapy, said coauthor Dieter Egli, PhD, an assistant professor of developmental cell biology (in pediatrics) at CUMC, who is also affiliated with the New York Stem Cell Foundation.
Dr. Tsang thinks this approach could also be used to study other forms of RP. Through genome-sequencing studies, hundreds of novel genetic spelling mistakes have been associated with RP, he said. But until now, weve had very few ways to find out whether these actually cause the disease. In principle, iPS cells can help us determine whether these genes do, in fact, cause RP, understand their function, and, ultimately, develop personalized treatments.
In normal, or wild-type, retinal cells (left), the protein actin forms the cells cytoskeleton, creating an internal support structure that looks like a series of connected hexagons. In cells with MFRP mutations (center), this structure fails to form, compromising cellular function. When diseased retinal cells are treated with gene therapy to insert normal copies of MFRP (right), the cells cytoskeleton and function are restored. (Image credit: Lab of Stephen H. Tsang, MD, PhD/Columbia University Medical Center.)
About:
The paper is titled, Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein (MFRP) defects. The other contributors are Yao Li (CUMC), Wen-Hsuan Wu (CUMC), Chun-Wei Hsu (CUMC), Huy V. Nguyen (CUMC), Yi-Ting Tsai (CUMC), Lawrence Chan (CUMC), Takayuki Nagasaki (CUMC), Irene H. Maumenee (Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL), Lawrence A. Yannuzzi (CUMC), Quan V. Hoang (CUMC), and Haiqing Hua (CUMC and NYSCF, New York, NY).
The authors declare no financial or other conflicts of interests.
The study was supported by grants from the National Institute of Health (5P30EY019007, 5P30CA013696, R01EY018213), Research to Prevent Blindness, the Tistou and Charlotte Kerstan Foundation, the Barbara and Donald Jonas Laboratory, the Schneeweiss Stem Cell Fund, New York State (N09G-302, N13G-275), a Foundation Fighting Blindness New York Regional Research Center Grant (C-NY05-0705-0312), the Joel Hoffman Fund, the Gale and Richard Siegel Stem Cell Fund, the Laszlo Bito and Olivia Carino Foundation, the Irma T. Hirschl Charitable Trust, the Bernard and Anne Spitzer Stem Cell Fund, the Professor Gertrude Rothschild Stem Cell Foundation, and the Gebroe Family Foundation.
Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, th
e School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cumc.columbia.edu or columbiadoctors.org.
CUMC on Twitter:@ColumbiaMed#CUMC CUMC on Facebook
See original here:
Patient-Specific Stem Cells and Personalized Gene Therapy ...
- Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact - MIT News - October 13th, 2022
- Weekly Roundup: FAO Food Price Index drops for sixth consecutive month, BlueNalu's new alt-seafood facility - Food Ingredients First - October 13th, 2022
- AVMA editor-in-chief becomes Equine Research Hall of Famer, with three others - American Veterinary Medical Association - September 25th, 2022
- Boosting Neuron Formation To Restore Memory in Alzheimers Disease - SciTechDaily - August 30th, 2022
- Illinois Innovation Network honors innovators from across state - University of Illinois - August 22nd, 2022
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size 2022 Industry Overview, Key Technology and Forecast Research 2030 - Taiwan News - August 22nd, 2022
- Animals could hold the key to human longevity. Here's why - Salon - August 22nd, 2022
- Light-activated technique helps bring cell powerhouses back into balance - University of Illinois Urbana-Champaign - August 5th, 2022
- 3D Cell Culture Market Anticipated to Achieve Lucrative Growth by 2030 with 3D Biotek, LLC, Advanced Biomatrix, Inc, Becton, Dickinson and Company,... - August 5th, 2022
- Single cell Analysis Market Is Likely To Witness Exponential Growth By 2030 | Danaher Corporatio, Merck Millipore, Qiagen N.V., Thermo Fisher... - August 5th, 2022
- Babys Cells Can Manipulate Moms Body for Decades - July 3rd, 2022
- Cell Expansion Market Projection By Top Key Players, Regional Analysis Revenue Forecast Till 2030 Designer Women - Designer Women - July 3rd, 2022
- Agriculture companies have lots of job openings in STEM fields, far from the farm - Illinois Newsroom - June 22nd, 2022
- 3D Cell Culture Market Size, Trends, Share, Research Report Study, Regional and Industry Analysis, Forecast to 2030 The Greater Binghamton Business... - June 4th, 2022
- 3D Cell Culture Market Size 2022 [NEW GROWTH AVENUES] Share, Key Findings, Investment Opportunities, and Forecast till 2030 | Thermo Fisher Scientific... - May 15th, 2022
- Primary Cells Market 2022 Share, Upcoming Trends, Growth Analysis, Latest Technology by 2030 |PromoCell GmbH, HemaCare Corporation, Thermo Fisher... - May 15th, 2022
- Jasper Therapeutics Announces Management Changes to Strengthen Leadership Team - BioSpace - March 25th, 2022
- Culture Media Market Outlook, Size, Share and Growth and Forecast Assumptions 2022-2030 - Taiwan News - March 25th, 2022
- Tissue Banking Market Growth Statistics 2022 Industry Demand, Share Evaluation, Prominent Players Strategies, Size, SWOT Analysis, COVID-19 Impacts,... - January 20th, 2022
- Researchers develop fast COVID-19 test using atom-thick sheets of graphene - FierceBiotech - June 23rd, 2021
- Researchers develop graphene-based sensors that detect COVID-19 quickly and efficiently - Graphene-Info - June 23rd, 2021
- From Roaches To Medical Emergencies, Illinois Inmates Say Theres Nobody That We Can Really Go To For Help - WBEZ - December 4th, 2020
- Get Up to Speed On the State of Eco-Fashion - NEO.LIFE - September 27th, 2020
- Universities aren't making a lot of money from university research - The Hechinger Report - January 18th, 2020
- Trees and seeds during the winter | Lifestyle - Fergus Falls Daily Journal - January 11th, 2020
- Biobots are hybrid machines that have muscles and nerves - DesignNews - November 25th, 2019
- Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells - PR... - October 5th, 2019
- Sperm-like biobots swim toward seeding stem cells - The Sociable - September 25th, 2019
- Scientists Create Tiny Soft Robots That Get Propelled by Muscles And Nerves - Mashable India - September 25th, 2019
- Scientists Built Tiny Robots Powered by Muscles and Nerves - Futurism - September 25th, 2019
- Vaping and e-cigarette warnings have been hiding in plain sight - ABC News - September 25th, 2019
- UIC launches Center for Stem Cell and Regenerative ... - September 12th, 2019
- Stem Cell Therapy | Illinois Pain Institute - April 26th, 2019
- High School Summer STEM Research Programs Worldwide ... - April 9th, 2019
- Stem Cells Treatment Chicago, Illinois, Chicago North ... - February 9th, 2019
- Stem Cells and Human Cloning - Illinois Right to Life - January 5th, 2019
- Illinois Stem Cell Clinic - Illinois Stem Cell Clinic ... - October 6th, 2018
- Regenerative Care Clinics of Illinois | Stem Cell Therapy ... - June 20th, 2018
- Stem Cell Therapy Chicago Illinois, Buffalo Grove ... - June 20th, 2018
- Stem Cell Therapy for Rotator Cuff Tears | Stem Cell ... - June 20th, 2018
- 'Happiness' Explores The Complex Push And Pull Of Human Relationships - NPR Illinois | 91.9 UIS - August 11th, 2017
- Origami Organs: This 'Tissue Paper' Could Help Regenerate a Heart or Uterus - Live Science - August 11th, 2017
- What's Propelling Neuralstem, Inc. (CUR) to Reach 52 Week Low? - WeeklyHub - August 1st, 2017
- The Telegraph | SIUE Odyssey Science Camp engages area ... - Alton Telegraph - August 1st, 2017
- That Time My Daughter Was On Medicaid - ChicagoNow (blog) - July 2nd, 2017
- Worlds Leading Pediatric Cardiology Congress | American ... - January 19th, 2017
- Prairie Heart - December 31st, 2016
- Regenerative Stem Cell Injections | Stem Cell Therapy Illinois - August 14th, 2016
- Stem Cell Research | Illinois Right to Life - August 3rd, 2016
- Mesenchymal stem cells in the treatment of spinal cord ... - November 1st, 2015
- Immunoglobulin (IG or Immune Globulin or Gamma Globulin) - November 1st, 2015
- From stem cells to billions of human insulin-producing ... - October 2nd, 2015
- Bone Marrow and Stem Cell Transplant | Loyola Medicine - June 21st, 2015
- Naperville Illinois Stem Cell Research | Naperville IL ... - June 10th, 2015
- Northwestern Medicine Investigates Using Stem Cells to Save Limbs from Amputation - April 3rd, 2015
- Cleveland BioLabs Reports Fourth Quarter and Fiscal 2014 Financial Results and Development Progress - February 27th, 2015
- Regenexx Stem Cell Treatments and Platelet Procedures ... - February 16th, 2015
- Students envision future cities with skyscraper farms - January 18th, 2015
- Live imaging captures how blood stem cells take root in the body - January 16th, 2015
- Hematopoietic stem cell - Wikipedia, the free encyclopedia - January 4th, 2015
- Cyanide killed hospital employee, official says - Quincy Herald-Whig | Illinois & Missouri News, Sports - November 30th, 2014
- Hematopoiesis from Pluripotent Stem Cells - November 19th, 2014
- 5. Hematopoietic Stem Cells [Stem Cell Information] - October 30th, 2014
- Saratoga Co. woman meets marrow donor who saved her life - October 12th, 2014
- Illinois (Stem Cell) - what-when-how In Depth ... - October 9th, 2014
- Julio Garcia, M.D. Recognized by National Alliance of Male Executives-N.A.M.E. - October 3rd, 2014
- Meso Foundation and University of Chicago Medicine Present Chicago Conference on Mesothelioma - October 1st, 2014
- News Bureau | University of Illinois - Stem cells aid ... - August 30th, 2014
- Stem Cell Grants - Illinois Department of Public Health - August 26th, 2014
- News Bureau | University of Illinois - Stem-cell approach ... - August 22nd, 2014
- Stem Cell Therapy Illinois | Stem Cell Treatments - August 22nd, 2014
- Ohio diocese discourages ALS ice bucket challenge - Quincy Herald-Whig | Illinois & Missouri News, Sports - August 22nd, 2014